BP000081-CYT-283: Recombinant Human IFNα 1b
Source: E. coli-derived.
The specific activity as determined in a viral resistance assay using bovine kidney MDBK cells was found to be 1 x 108 IU/ mg.
Purity > 96%, by SDS--PAGE and RP-HPLC.BP000080-CYT-520: Recombinant Human IFNα 1a
Source: E. coli-derived.
The specific activity as determined in a viral resistance assay viral ressistance assay was found to be 1 x 100,000,000 IU/ mg.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000079-CYT-291: Recombinant Human IFNα 1
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP000077-CYT-467: Recombinant Human Desert Hedgehog
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP000073-CYT-427: Recombinant Human Pro Bone Morphogenetic Protein-2
Source: E. coli-derived.
The ProBMP-2 Human Recombinant administration leads to ectopic bone formation ion rats.
Purity > 98%, by SDS-PAGE and RP-HPLC.BP000069-CYT-659: Recombinant Human Growth differentiation factor 10
Source: E. coli-derived.
Purity > 95%, by SDS--PAGE.BP000062-CYT-461: Recombinant Human Beta Defensin-3 (BD 3) Protein
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000061-CYT-571: Recombinant Human Beta-Defensin 2 (BD-2) Protein
Source: E. coli-derived.
The specific activity is determined by the ability to chemoattract human dendritic immature cells at a concentration of 10-100 ug/ml.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP002853-PRO-081: Recombinant human GRAP2 Protein
Source: E. coli-derived.
Purity: > 90% as determined by SDS-PAGE.BP001820-ALR-003: Recombinant Major mite fecal allergen Der p 1 (Der P1) Protein
Source: E. coli-derived.
Purity: >95% by 10% SDS-PAGE (coomassie staining).